Close Menu

stock offering

The company estimated that the offering could raise between $327.2 and $376.3 million, which it would use for various corporate purposes.

The company, based in Fort Myers, Florida, said that it plans to use the net proceeds from the offering for general corporate purposes.

The firm sold 4.31 million shares after the underwriters fully exercised their options to purchase 562,500 shares at the offering price of $21 per share.

The company will offer 3.75 million shares of its common stock at $21 per share.

The company will use the proceeds to expand its R&D capabilities and its commercial operations.

The company plans to offer 5.5 million shares of its common stock at $23.25 per share, raising around $127.9 million.

The company will use the proceeds for working capital and to repay around $12.4 million of its term loan.

The firm is selling more than 5.2 million shares at an offering price of $19 per share.

To help fund the acquisition, Yourgene Health is planning to sell at least £10.0 million in newly issued shares to institutional investors.

The firm expects to offer nearly 5 million shares and also noted that this week it entered into an amended credit facility.

Pages

Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.

An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.

Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.

In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.